The IAB, comprised of senior executives from both small and large pharmaceutical and biomedical technology companies, assists in the academic leadership of the department in several ways: programmatic direction, student employment and technology transfer. The IAB directly influences the general education and research programs of the Department, and ensures that the needs, insights, and objectives of industry are understood by our faculty and students.
Industrial Advisory Board Members
Dr. Simon J. Archibald
Chief Scientist
Integra LifeSciences, Plainsboro, NJ 08536
Dr. Christopher Damien, ENG'90
Corporate Director of Biotechnology
Dentsply, York, PA
Dr. Lance Ladic
Director, Strategic Innovation
Siemens Corporation, Princeton, NJ
Dr. Thomas Linden
Director, Bioprocess Development
Merck, Rahway, NJ
Mr. Mir Imran, ENG'77
President
In Cube, Inc, Menlo Park, CA
Dr. William Olson
Vice President Research and Development
Progenics Pharmaceutical, Tarrytown, NY
Dr. Scott Rakestraw
President
The Branta Group, Pennsylvania
Dr. Greg Russotti, ENG'97
Vice President, Technical Operations
Celgene Cellular Therapeutic, Warren, NJ
Dr. Kambiz Shekdar
Director, Product Development
Chromocell Corporation, North Brunswick, NJ
Dr. Meg Smith
Vice Presiden, Product Development Systems
Stryker, Mahwah, NJ
Dr. Howard Weintraub
Principal Engineer
Landfall Therapeutic Consulting Group, Princeton, NJ
Dr. Michael Yamin
Director, Technology Development
Warren Pharmaceuticals, Inc., New Brunswick, NJ
Dr. Mark Zimmerman, ENG'82
Venture Leader
Janssen Research and Development, LLC, J&J Comp., NJ